Synbiotic Dessert Fortified with Vitamin D and Calcium in Hemodialysis Patients
Phase 3
- Conditions
- Chronic kidney disease, stage 5, End stage kidney disease: on dialysisHemodialysis.
- Registration Number
- IRCT20100223003408N5
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Patients who are on dialysis more than 6 months
Patients with KT/V > 1.2
Patients who are vigilant and can-do
Who are on special regiment for dialysis patients
Patients who did not have any changes in their recieved erythropoitin for a month
Exclusion Criteria
Patients with diabetes, cancer, malignity and autoimmune diseases
Patients who are sensitive to dairy products
Patients who are grafted and grafted kidney is in their body
Patients with vitamin D level more than 70
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Malondialdehyde (MDA). Timepoint: Before and 60 days after intervention. Method of measurement: Spectrophotometry.
- Secondary Outcome Measures
Name Time Method